Stock Analysis
3M CompanyMMM
P/E 28.35×· 5Y range 8.72–82.11×· top 14% of history
Sector: Healthcare · Industry: Surgical & Medical Instruments & Apparatus
AnalystsBuy24 analystsP/E 28.4× sits at the 86th percentile of its 5.086926762491444-year history.
Cash covers 40% of debt · Q2 2026.
PMP Verdict
Mixed fundamentals, expensive valuation
Strengths
- Profitability90
- Financial Health74
Risks
- Valuation44
- Growth25
Mixed fundamentals at a demanding price.
Bull Case
- ✓Altman Z 3.9 — safe-zone balance sheet
- ✓ROE 99.7% — efficient capital deployment
- ✓Interest coverage 14.5× — debt well covered
What's happening with MMM
Profile
Strong profitability; growth and valuation lag behind.
How is each axis scored?
- Valuation44/100 · Weak
- P/E vs own history (86th pct)0/25
- FCF yield (4.7%)12/25
- P/S (3.4x)20/25
- EV/EBIT (20.1x)12/25
- Growth25/100 · Weak
- Revenue CAGR (-8.3%)0/25
- Net income CAGR (-13.9%)0/25
- EPS CAGR 5Y (-12.2%)0/25
- Fwd implied growth (60.2%)25/25
- Profitability90/100 · Strong
- ROIC (33.6%)25/25
- ROE (99.7%)25/25
- Net margin (11.9%)20/25
- Operating margin (18.4%)20/25
- Financial Health74/100 · Moderate
- Altman Z (3.86)25/25
- Current ratio (1.24)12/25
- Interest coverage (14.5x)25/25
- Net cash / debt (D/A 22%)12/25
- Quality72/100 · Moderate
- Piotroski F (6/9)15/25
- Beneish M (-2.36)20/25
- FCF conversion (133%)25/25
- Margin stability (σ 8.5%)12/25
- Moat65/100 · Moderate
- ROIC >12% years (8/10 yrs)20/25
- Median gross margin (46.8%)20/25
- FCF-positive years (10/10 yrs)25/25
- Worst-year net margin (worst -21.4%)0/25
Risk Flags
- ⚠Revenue shrinking 8.3%/yr
- ⚠P/E 28.4× at top 14% of 5-year history
About 3M Company
3M, a multinational conglomerate founded in 1902, sells tens of thousands of products ranging from sponges to respirators. Show more
The firm is well known for its extensive research and development capabilities, and it is a pioneer in inventing new use cases for its proprietary technologies. 3M is organized across three business segments: safety and industrial (representing around 44% of revenue), transportation and electronics (36%), and consumer (20%). The firm recently spun off its healthcare business, now known as Solventum. Nearly half of 3M's revenue comes from outside the Americas.
Headquarters: ST PAUL, MN · Employees: 60,500 · Website ↗
Price History
Weekly Candlestick Chart — up to 5Y
Key Metrics
Financial snapshot · Tap any metric for its definition and grade
TTM Snapshot
trailing twelve months · YoYValuation
44D+P/E (TTM)28.4xC
Grade C: ExpensivePrice / TTM EPS (own statements) — vs own 5Y history: 8.7x–82.1x · 86th pct
P/FCF21.5xB
Grade B: FairPrice / Free Cash Flow per share (Finnhub). Inverse of FCF yield — negative when FCF is negative
FCF Yield4.7%C
Grade C: LowTTM (OCF − CapEx) / Market Cap — vs own 5Y history: -2.5%–10.2% · 38th pct
P/S (TTM)3.38xB
Grade B: FairPrice / TTM Revenue (own statements) — vs own 5Y history: 1.4x–3.8x · 81st pct
EV/EBIT20.1xC
Grade C: ExpensiveEnterprise value / TTM EBIT (D&A not in our data) — capital-structure neutral — vs own 5Y history: 15.8x–20.6x · 81st pct
EV/Sales3.8xB
Grade B: FairEnterprise Value / TTM Revenue (Finnhub) — capital-structure neutral sales multiple
Forward P/E17.7xB
Grade B: FairPrice / next-year EPS estimate — shows whether the TTM multiple is rich or just front-loading growth
P/B Ratio28.32xD
Grade D: Very expensivePrice to Book Value. Neg. equity = heavy buybacks
PEG Ratio—
Finnhub PEG — their P/E basis ÷ expected EPS growth. Suppressed when their P/E diverges >2× from our TTM P/E (different basis)
Dividend Yield1.86%A
Grade A: PaysTTM dividend yield (Finnhub) — annual dividends / price. None = no dividend; very high yield can signal distress
Payout Ratio53.0%A
Grade A: SafeDividends / Net Income (Finnhub) — share of earnings paid out; >90% or negative = unsustainable
Profitability
90A+ROIC33.6%A
Grade A: MoatNOPAT (EBIT less ~21% tax) / invested capital (equity + debt − cash). Flagship quality metric — durable >15% signals a moat
ROE99.7%A
Grade A: StrongReturn on Equity. Neg. equity = heavy buybacks
ROA8.2%C
Grade C: AverageReturn on Assets (Finnhub) — Net Income / Total Assets; how efficiently assets produce profit
Net Margin11.9%A
Grade A: HighNet Income / Revenue
Operating Margin18.4%C
Grade C: AverageTTM EBIT / TTM Revenue
Gross Margin39.4%C
Grade C: AverageGross Profit / Revenue
FCF Margin15.8%A
Grade A: HighFCF / Revenue
True FCF Margin15.0%A
Grade A: HighTTM (OCF − CapEx − SBC) / TTM Revenue — SBC treated as a real cost
Growth
25ERevenue CAGR-8.3%D
Grade D: LowCompound annual revenue growth (up to 5Y depending on data availability)
Net Income CAGR-13.9%D
Grade D: LowCompound annual net income growth (up to 5Y depending on data availability)
EPS CAGR (5Y)-12.2%D
Grade D: LowCompound annual EPS growth over up to 5Y of per-share earnings (own statements). Null when either endpoint EPS ≤ 0
Implied EPS Growth60.2%A
Grade A: HighAnalyst forward EPS (normalized basis) vs our GAAP TTM EPS — different bases, so extreme values usually mark cyclically depressed TTM earnings, not real growth
Dilution (5Y)-12.2%A
Grade A: BuybacksShare count change over 5Y
SBC / Net Income7.2%A
Grade A: LowStock-based comp/Net income. >30% = dilution risk
SBC / Revenue0.9%A
Grade A: LowTTM stock-based comp / TTM Revenue
Financial Health
74B+Altman Z-Score3.86A
Grade A: SafeBankruptcy risk. >3 Safe, <1.8 Distress
Current Ratio1.24xC
Grade C: OkCurrent Assets/Liabilities
Quick Ratio0.87xC
Grade C: Ok(Current Assets − Inventory) / Current Liabilities (Finnhub) — stricter liquidity test, excludes inventory
Interest Coverage14.5xA
Grade A: StrongEBIT/Interest. >10 Strong
Debt Repayment2.0yA
Grade A: FastYears to repay net debt via FCF
Net Debt/EBIT1.7xA
Grade A: LowLeverage. <2x Low, >4x High
Debt/Equity4.38xD
Grade D: HighDebt / Equity: <1 Conservative, >2 Risky. Not meaningful with non-positive equity; shown as unavailable rather than low debt.
Cash / Debt0.40xC
Grade C: PartialCash covers how much of total debt. >1 = could repay all debt from cash
Quality
72B+Piotroski F-Score6/9C
Grade C: AverageFinancial strength 0–9. >7 Strong
Beneish M-Score-2.36A
Grade A: SafeEarnings manipulation risk. < -2.22 Safe
FCF Conversion133.0%A
Grade A: StrongFCF / Net Income
Margin Stability8.5%C
Grade C: AverageEBIT margin std deviation. Lower = stable
Capex / Revenue3.6%A
Grade A: Asset-lightTTM CapEx / TTM Revenue — high % = capital-hungry business
Asset Turnover0.69xC
Grade C: AverageRevenue / Total Assets (Finnhub) — how efficiently the asset base generates sales
Insider Transactions
SEC Form 4 · 8 recordsP/S codes are the directional signal; grants, option exercises and tax withholding carry none. Form 4 doesn't flag 10b5-1 plans — scheduled sales may appear within open-market sells.
| Trade date | Insider | Transaction | Shares | Filed |
|---|---|---|---|---|
Kshirsagar Tushar A. Filed | Kshirsagar Tushar A. | Option exercise | -53 | |
Kshirsagar Tushar A. Filed | Kshirsagar Tushar A. | Tax withholding | -53 | |
Kshirsagar Tushar A. Filed | Kshirsagar Tushar A. | Option exercise | +53 | |
Goralski Christian T JR Filed | Goralski Christian T JR | Option exercise | -217 | |
Goralski Christian T JR Filed | Goralski Christian T JR | Option exercise | -219 |
Show 3 more filingsShow fewer filings
| Trade date | Insider | Transaction | Shares | Filed |
|---|---|---|---|---|
Goralski Christian T JR Filed | Goralski Christian T JR | Option exercise | -1288 | |
Goralski Christian T JR Filed | Goralski Christian T JR | Tax withholding | -1724 | |
Goralski Christian T JR Filed | Goralski Christian T JR | Option exercise | +217 |
Option exercise (M) rows report a derivative leg, not an open-market sale — a paired negative entry is the option position being consumed.
More metrics — Moat, Per Share, Balance Sheet, MarketHide additional metrics
Moat
65BROIC >12% Years8/10 yrsA
Grade A: DurableShare of completed fiscal years with ROIC > 12% — measures multi-year capital-return durability
Gross Margin (Med.)46.8%A
Grade A: DurableMedian annual gross margin across available fiscal years — pricing-power durability
FCF-Positive Years10/10 yrsA
Grade A: DurableShare of completed fiscal years with positive free cash flow
Net Margin Floor-21.4%D
Grade D: WeakWeakest annual net margin across completed fiscal years — recession/downcycle resilience
Per Share
EPS (TTM)$5.81
Own TTM net income / shares — same earnings basis as P/E
Cash / Share$6.46
Cash & short-term investments per share (Finnhub)
Book Value / Share$5.72
Shareholders' equity per share (Finnhub). Negative = accumulated losses / heavy buybacks
Balance Sheet
Total Debt$13.16B
Total debt obligations (short + long term)
Cash & Equiv.$5.30B
Cash and short-term investments
Net Debt$7.86B
Total Debt minus Cash. Negative = Net Cash position
Total Equity$3.00B
Shareholders' equity (book value)
Asset / Liability1.09xC
Grade C: AdequateTotal Assets / Total Liabilities
Market
Market Cap$85.09B
Current Market Capitalization
Beta1.01B
Grade B: MarketPrice sensitivity vs the market (Finnhub) — 1.0 moves with market, >1.2 amplifies swings
How grades work: each metric is graded A–D against fixed thresholds (tap a row for the meaning). Card grades map the pillar score to A+–E — a card grade is that pillar's own score, not an average of the rows shown.
Financials as of Jun 2026 · Ratio snapshot Oct 17, 2026
Key Insights: 3M Company (MMM)
Piotroski F-Score of 6/9 indicates mixed fundamentals for 3M Company. Altman Z-Score of 3.86 sits comfortably in the safe zone (≥ 2.99), indicating low bankruptcy risk. Beneish M-Score of -2.36 suggests a low likelihood of earnings manipulation. Revenue has been contracting (CAGR ≈ -8%), which weighs on the growth outlook.
- 3M Company converts about 16% of revenue into free cash flow — strong cash generation.
- Takes ~2.0 years to repay net debt from free cash flow.
- 3M Company posted a net loss in 1 of 10 available completed fiscal years (2016–2025).
- Return on equity of 99.7% is well above the market average.
See how MMM ranks on the Capex Tracker — top 50 capital spenders compared.
Recent Market Moves
See all MMM moves →| Date | Session | Price | Move | Z-Score |
|---|---|---|---|---|
| Sep 30 | After-hours | 163.71 | -2.84% | -2.30 |
| Sep 22 | Regular | 168.61 | +2.21% | 2.34 |
| Sep 22 | After-hours | 169.30 | +2.62% | 2.71 |
Frequently Asked Questions about MMM
What is the current 3M Company (MMM) stock price?
MMM is trading at $164.75 at the last market close, down 0.35% on the session. PreMarketPrice tracks MMM pre-market, intraday and after-hours prices.
Is MMM stock a buy right now?
PreMarketPrice's quantitative model rates 3M Company's financial health at 74/100. This is a data-driven snapshot of fundamentals, not investment advice.
Is MMM stock overvalued?
3M Company trades at a trailing P/E of 28.4 and our valuation score rates it 44/100 (higher = cheaper vs. its own history). See the Valuation History and Key Metrics sections for forward P/E, EV/EBITDA and PEG context.
When does 3M Company report earnings?
No confirmed earnings date is currently scheduled for MMM. The Earnings section lists recent reports and updates as dates are announced.
What sector does 3M Company operate in?
3M Company operates in the Healthcare sector, within the Surgical & Medical Instruments & Apparatus industry. The Related Stocks section lists sector peers for comparison.
What does 3M Company do?
3M, a multinational conglomerate founded in 1902, sells tens of thousands of products ranging from sponges to respirators.
About 3M Company (MMM) Stock
3M Company (MMM) is a US-listed stock operating in the Healthcare sector, specifically the Surgical & Medical Instruments & Apparatus industry. As of the latest update, 3M Company is trading at $164.75, down 0.35% on the day with a market capitalization of $85.1 billion. The financial health score for MMM is 74/100, which indicates good financial strength based on profitability, leverage, liquidity, and growth metrics. This page provides real-time pre-market pricing, earnings calendar, financial health analysis, and valuation metrics for MMM stock.
MMM Stock Analysis & Key Metrics
On PreMarketPrice, you can track 3M Company (MMM) across multiple dimensions:
- Pre-market price & movement: Real-time MMM stock price with percentage change, updated continuously during pre-market and regular trading hours.
- Valuation & P/E history: Historical P/E, P/S, and P/B ratios for MMM with trend analysis and normalized valuation multiples.
- Financial statements: Revenue, net income, assets, liabilities, and equity for 3M Company across multiple reporting periods.
- Financial health score: A composite score of 74/100 based on Altman Z-Score, Piotroski F-Score, profitability, and leverage metrics for MMM.
- Sector peers: Compare MMM against 6 other healthcare stocks on key financial metrics.
Is MMM a Good Stock to Buy?
This page provides data-driven analysis to help you evaluate 3M Company (MMM) as an investment. The financial health score of 74/100 suggests good financial fundamentals. Valuation metrics show whether the stock is trading above or below its historical average.However, this is not financial advice — always do your own research before investing.
Data on this page is sourced from real-time market feeds, Polygon.io, and Finnhub.3M Company (MMM) trades on NYSE/NASDAQ. Pre-market trading occurs 4:00 AM – 9:30 AM ET. Regular market hours are 9:30 AM – 4:00 PM ET.